advertisement

Topcon

Tanito M 10

Showing records 1 to 10 | Display all abstracts from Tanito M

109253 A case of two connected stents deployed during iStent inject W surgery
Shimada A
BMC Ophthalmology 2023; 23: 206
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Inatani M
Advances in Therapy 2023; 40: 4074-4092
109967 Nationwide Analysis of Glaucoma Surgeries in Fiscal Years of 2014 and 2020 in Japan
Tanito M
Journal of personalized medicine 2023; 13:
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Orii Y
Advances in Therapy 2023; 40: 4074-4092
109253 A case of two connected stents deployed during iStent inject W surgery
Ichioka S
BMC Ophthalmology 2023; 23: 206
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Iwasaki K
Advances in Therapy 2023; 40: 4074-4092
109253 A case of two connected stents deployed during iStent inject W surgery
Ishida A; Kaidzu S
BMC Ophthalmology 2023; 23: 206
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Arimura S; Sunagawa H
Advances in Therapy 2023; 40: 4074-4092
109253 A case of two connected stents deployed during iStent inject W surgery
Tanito M
BMC Ophthalmology 2023; 23: 206
109855 Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
Shiokawa M; Inoue K; Sakono T; Sakono T; Kuwamura R; Yoshida A; Oi J; Kuwayama Y; Kano K; Kido N; Matsuyama A; Ozaki M; Abe H; Inoue C; Nakagawa S; Musashi K; Kanamori A; Lee J; Otani S; Aoki R; Tanabe H; Nakakura S; Suzuki K; Sagara T; Saito Y; Sameshima M; Urahashi M; Watanabe-Kitamura F; Inoue T; Kagaya F; Murai Y; Mori S; Ueda K; Kurimoto T; Yamada-Nakanishi Y; Yamada-Nakanishi Y; Nakamura M; Yamashita T; Ishiyama S; Manabe S; Takaki K; Hayashi K; Ishida A; Tsutsui A; Tsutsui A; Manabe K; Tanito M
Advances in Therapy 2023; 40: 4074-4092

Issue 24-1

Change Issue


advertisement

Oculus